Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00772707 · ClinicalTrials.gov registry record · NA

A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)

A NA study of Myopia, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
114
Enrollment target
1
Study location

NCT00772707 is a NA study of Myopia that has completed, run by Alcon Research. The registered enrollment target is 114 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00772707, a NA study of Myopia, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
114 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.

Conditions Studied

Interventions

  • DEVICE Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH)
  • DEVICE Contact Lenses

Study Locations (1)

Texas

  • Alcon Call Center for Trial Locations - Fort Worth

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2008-09
Est. Completion 2008-10
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT00772707

The ClinicalTrials.gov registry entry for NCT00772707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (57% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH) is the first listed.

NCT00772707 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00772707 about?

NCT00772707 is a clinical study titled "A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)". The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.

What is the current status of trial NCT00772707?

This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2008-09. Estimated completion is 2008-10.

What conditions does trial NCT00772707 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT00772707?

The interventions under investigation include: Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH) (DEVICE), Contact Lenses (DEVICE).

Who is sponsoring clinical trial NCT00772707?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00772707 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.